The Latest Breaking News from Pfizer

Moderna’s updated COVID-19 booster shot shows even more efficiency against variants, the pharmaceutical company announced Tuesday, citing preliminary results from a trial.

Global demand for Pfizer Inc's (NYSE: PFE) Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced testing, and potential for drug interactions, a 

Japan’s health ministry formally approved Novavax’s COVID-19 vaccine, a fourth foreign-developed tool to combat the infections

Researchers from King's College London are working on regenerating damaged hearts in the hope of developing a cure for heart attacks - with human trials set to begin within two years.

Reuters reported that two patients found relief from long COVID after taking Pfizer Inc's (NYSE:PFE) antiviral Paxlovid, including a researcher who tested it on herself. Long COVID is estimated to affect up to 30% of people infected with the coronavirus. It can last for months.  More than 200 symptoms have been associated with the…

Researchers from King's College London have found a way to stimulate the creation of healthy heart cells - which can then be delivered to the muscle using the same technology used with the Moderna and Pfizer Covid vaccines

Should you get in line for a second booster ASAP?

SACRAMENTO, Calif. — California Democrats were moving toward requiring COVID-19 vaccines for students and keeping them from opting out of shots with personal belief exemptions.

Pfizer and Raytheon are among 5 stocks near buy points that offer protection from geopolitics and aggressive rate-hikes.